CN Patent
CN106496014A — 一种二氟尼柳的制备方法
Assigned to Hebei Maison Chemical Co Ltd · Expires 2017-03-15 · 9y expired
What this patent protects
一种二氟尼柳的制备方法,属于药物合成的技术领域,采用钯催化的Suzuki偶联反应,以2,4‑二氟苯硼酸与5‑卤代水杨酸为原料,在碱存在条件下,于有机溶剂中进行反应,向反应体系中加入相转移催化剂,控制2,4‑二氟苯硼酸与5‑卤代水杨酸的摩尔比为1:(0.8‑1.5)。本发明采用Suzuki交叉偶联反应,一步合成,操作简单,产品产率好,纯度高,具有工业应用前景。
USPTO Abstract
一种二氟尼柳的制备方法,属于药物合成的技术领域,采用钯催化的Suzuki偶联反应,以2,4‑二氟苯硼酸与5‑卤代水杨酸为原料,在碱存在条件下,于有机溶剂中进行反应,向反应体系中加入相转移催化剂,控制2,4‑二氟苯硼酸与5‑卤代水杨酸的摩尔比为1:(0.8‑1.5)。本发明采用Suzuki交叉偶联反应,一步合成,操作简单,产品产率好,纯度高,具有工业应用前景。
Drugs covered by this patent
- Vyndaqel (Tafamidis Meglumine) · Foldrx Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.